Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010
Wed, July 21, 2010
Tue, July 20, 2010
[ Tue, Jul 20th 2010 ] - Market Wire
00 AM EDT
Mon, July 19, 2010
Sun, July 18, 2010
Sat, July 17, 2010
Fri, July 16, 2010
Thu, July 15, 2010
Wed, July 14, 2010
Tue, July 13, 2010
Mon, July 12, 2010

Incyte to Report Second Quarter 2010 Financial Results and Provide Update on Drug Discovery & Development Programs on August 5


//health-fitness.news-articles.net/content/2010/ .. -discovery-development-programs-on-august-5.html
Published in Health and Fitness on Tuesday, July 20th 2010 at 13:25 GMT by Market Wire   Print publication without navigation


WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter 2010 financial results conference call for 8:30 a.m. ET on Thursday, August 5, 2010. The schedules for the press release and conference call are as follows:

-- Q2 2010 Press Release: August 5, 2010 at 7:00 a.m. ET
-- Q2 2010 Conference Call: August 5, 2010 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-269-7756
-- International Dial In Number: 201-689-7817
-- Conference ID # 354043

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 354043.

The conference call will also be webcast live on CCBN and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. Incytea™s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].


Publication Contributing Sources